Generation of Scalable Hepatic Micro-Tissues as a Platform for Toxicological Studies

[1]  H. Baharvand,et al.  Generation of Transplantable Three-Dimensional Hepatic-Patch to Improve the Functionality of Hepatic Cells in vitro and in vivo. , 2019, Stem cells and development.

[2]  Seung‐Woo Cho,et al.  Tissue Beads: Tissue‐Specific Extracellular Matrix Microbeads to Potentiate Reprogrammed Cell‐Based Therapy , 2019, Advanced Functional Materials.

[3]  R. Kamm,et al.  Self-organization of hepatocyte morphogenesis depending on the size of collagen microbeads relative to hepatocytes , 2019, Biofabrication.

[4]  M. Soleimani,et al.  Hybrid poly‐l‐lactic acid/poly(ε‐caprolactone) nanofibrous scaffold can improve biochemical and molecular markers of human induced pluripotent stem cell‐derived hepatocyte‐like cells , 2018, Journal of cellular physiology.

[5]  R. Laaksonen,et al.  hiPSC‐derived hepatocytes closely mimic the lipid profile of primary hepatocytes: A future personalised cell model for studying the lipid metabolism of the liver , 2018, Journal of cellular physiology.

[6]  H. Baharvand,et al.  Three‐dimensional liver‐derived extracellular matrix hydrogel promotes liver organoids function , 2018, Journal of cellular biochemistry.

[7]  A. Mathias,et al.  Cytochrome P450 3A Induction Predicts P‐glycoprotein Induction; Part 2: Prediction of Decreased Substrate Exposure After Rifabutin or Carbamazepine , 2018, Clinical pharmacology and therapeutics.

[8]  T. Pohlemann,et al.  Dissociation of mono- and co-culture spheroids into single cells for subsequent flow cytometric analysis. , 2018, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[9]  T. Takebe,et al.  Paracrine signals regulate human liver organoid maturation from induced pluripotent stem cells , 2017, Development.

[10]  Salman R Khetani,et al.  Engineered Liver Platforms for Different Phases of Drug Development. , 2017, Trends in biotechnology.

[11]  H. Baharvand,et al.  Effect of Secreted Molecules of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells on Acute Hepatic Failure Model. , 2016, Stem cells and development.

[12]  Hitomi Shirahama,et al.  Extracellular Matrix Functionalization and Huh-7.5 Cell Coculture Promote the Hepatic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells in a 3D ICC Hydrogel Scaffold. , 2016, ACS biomaterials science & engineering.

[13]  M. Ingelman-Sundberg,et al.  Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease , 2016, Scientific Reports.

[14]  Steven D. Webb,et al.  Characterization of a functional C3A liver spheroid model , 2016, Toxicology research.

[15]  A. Atala,et al.  Stiffness of hyaluronic acid gels containing liver extracellular matrix supports human hepatocyte function and alters cell morphology. , 2016, Journal of the mechanical behavior of biomedical materials.

[16]  Y. Li,et al.  Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting , 2016, Proceedings of the National Academy of Sciences.

[17]  Nupura S. Bhise,et al.  A liver-on-a-chip platform with bioprinted hepatic spheroids , 2016, Biofabrication.

[18]  Paul D. Martin,et al.  Effects of CYP3A4 Inhibitors Ketoconazole and Verapamil and the CYP3A4 Inducer Rifampicin on the Pharmacokinetic Parameters of Fostamatinib: Results from In Vitro and Phase I Clinical Studies , 2016, Drugs in R&D.

[19]  Stefan Wölfl,et al.  In Vitro Generation of Functional Liver Organoid-Like Structures Using Adult Human Cells , 2015, PloS one.

[20]  Layla Bashir Larsen,et al.  Fabrication of scalable and structured tissue engineering scaffolds using water dissolvable sacrificial 3D printed moulds. , 2015, Materials science & engineering. C, Materials for biological applications.

[21]  Rosalind E. Jenkins,et al.  Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[22]  M. D. Davidson,et al.  Microengineered Liver Tissues for Drug Testing , 2015, Journal of laboratory automation.

[23]  Slobodan Rendic,et al.  Survey of Human Oxidoreductases and Cytochrome P450 Enzymes Involved in the Metabolism of Xenobiotic and Natural Chemicals , 2014, Chemical research in toxicology.

[24]  Stefan Przyborski,et al.  Advances in 3D cell culture technologies enabling tissue‐like structures to be created in vitro , 2014, Journal of anatomy.

[25]  Jay D. Humphrey,et al.  Mechanotransduction and extracellular matrix homeostasis , 2014, Nature Reviews Molecular Cell Biology.

[26]  Sangeeta N. Bhatia,et al.  Cell and tissue engineering for liver disease , 2014, Science Translational Medicine.

[27]  S. Utley,et al.  Fibroblast growth factor signaling regulates the expansion of A6-expressing hepatocytes in association with AKT-dependent β-catenin activation. , 2014, Journal of hepatology.

[28]  B. Herpers,et al.  A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies , 2014, Archives of Toxicology.

[29]  S. Bhatia,et al.  Pluripotent stem cell-derived hepatocyte-like cells. , 2014, Biotechnology advances.

[30]  M. Bouchard,et al.  Layered long-term co-culture of hepatocytes and endothelial cells on a transwell membrane: toward engineering the liver sinusoid , 2013, Biofabrication.

[31]  V. K. Raghunathan,et al.  Characterizing the effects of heparin gel stiffness on function of primary hepatocytes. , 2013, Tissue engineering. Part A.

[32]  F. Sonntag,et al.  A dynamic multi-organ-chip for long-term cultivation and substance testing proven by 3D human liver and skin tissue co-culture. , 2013, Lab on a chip.

[33]  Eva-Maria Materne,et al.  Chip-based liver equivalents for toxicity testing--organotypicalness versus cost-efficient high throughput. , 2013, Lab on a chip.

[34]  K. Sekine,et al.  Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.

[35]  Dave T. Gerrard,et al.  Proteome-wide analyses of human hepatocytes during differentiation and dedifferentiation , 2013, Hepatology.

[36]  T. Singer,et al.  A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity. , 2013, Toxicology and applied pharmacology.

[37]  K. Kanda,et al.  3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing. , 2013, Biomaterials.

[38]  Hartmut Jaeschke,et al.  Acetaminophen-induced liver injury in rats and mice: comparison of protein adducts, mitochondrial dysfunction, and oxidative stress in the mechanism of toxicity. , 2012, Toxicology and applied pharmacology.

[39]  A. Barbetta,et al.  A biomimetic porous hydrogel of gelatin and glycosaminoglycans cross-linked with transglutaminase and its application in the culture of hepatocytes , 2012, Biomedical materials.

[40]  Catarina Brito,et al.  Human liver cell spheroids in extended perfusion bioreactor culture for repeated‐dose drug testing , 2012, Hepatology.

[41]  K. Suh,et al.  Patterning Methods for Polymers in Cell and Tissue Engineering , 2012, Annals of Biomedical Engineering.

[42]  Enrico Drioli,et al.  Human hepatocytes and endothelial cells in organotypic membrane systems. , 2011, Biomaterials.

[43]  A. Poso,et al.  New in vitro tools to study human constitutive androstane receptor (CAR) biology: discovery and comparison of human CAR inverse agonists. , 2011, Molecular pharmaceutics.

[44]  S. Rees,et al.  Principles of early drug discovery , 2011, British journal of pharmacology.

[45]  M. Yarmush,et al.  Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance , 2009, Proceedings of the National Academy of Sciences.

[46]  B. Sáinz,et al.  Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection , 2009, Virology Journal.

[47]  Tammy T. Chang,et al.  Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes. , 2009, Tissue engineering. Part A.

[48]  B. Lake,et al.  Induction of drug metabolism: species differences and toxicological relevance. , 2008, Toxicology.

[49]  Hayley S. Brown,et al.  Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies , 2007, Drug metabolism reviews.

[50]  Paul B Watkins,et al.  Drug‐induced liver injury: Summary of a single topic clinical research conference , 2006, Hepatology.

[51]  Neil Kaplowitz,et al.  Idiosyncratic drug hepatotoxicity , 2005, Nature Reviews Drug Discovery.

[52]  Smadar Cohen,et al.  Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions , 2004, Biotechnology and bioengineering.

[53]  H. Kroemer,et al.  The ABC Transporters MDR1 and MRP2: Multiple Functions in Disposition of Xenobiotics and Drug Resistance , 2004, Drug metabolism reviews.

[54]  J. Shieh,et al.  The Catalytic Center of Glucose-6-phosphatase , 2002, The Journal of Biological Chemistry.

[55]  P. Moghe,et al.  Control of hepatocyte function on collagen foams: sizing matrix pores toward selective induction of 2-D and 3-D cellular morphogenesis. , 2000, Biomaterials.

[56]  K. Zaret,et al.  Initiation of mammalian liver development from endoderm by fibroblast growth factors. , 1999, Science.

[57]  K. Lilley,et al.  Proteomic responses of HepG2 cell monolayers and 3D spheroids to selected hepatotoxins. , 2019, Toxicology letters.

[58]  Line,et al.  University of Southern Denmark Determination of Drug Toxicity Using 3D Spheroids Constructed From an Immortal Human Hepatocyte Cell Line , 2012 .